Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
15 /100
LOW RISK
Score updated Oct 13, 2026

LGND — Ligand Pharmaceuticals Incorporated Dilution Risk Tracker

Track LGND dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LGND — Get alerts when the score changes →

As of October 13, 2026, Ligand Pharmaceuticals Incorporated (LGND) has a DilutionWatch DilutionScore of 15/100, rated LOW dilution risk. Ligand Pharmaceuticals Incorporated has a market capitalization of $6.20B, 19.94M shares outstanding, 360 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰Cash Runway—
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄 Convertible Debt
35

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
🔁 Convertible Conversion model 15%
• Convertible debt present: 7.6% potential dilution
🔔 Track LGND — Get forecast alerts →

Market Data

Market Cap$6.20B
Shares Outstanding19.94M
Float19.57M
Cash$1.36B
Debt$1.13B
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore15/100DilutionWatch score record
Shares Outstanding19.94MVerified float table or market cache
Public Float19.57MVerified float table or market cache
Market Cap$6.20BMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 15.2% shares (2026Q1 vs prior)
360 institutional holders · 24.14M shares
#1 BlackRock, Inc. 2.96M shares
#2 JANUS HENDERSON GROUP PLC 2.02M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 1.70M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.68M
Days to Cover8.7
% of Float13.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-02-27
xbrl XBRL WARRANT 2025-02-28
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-03-31
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual LGND Dilution Snapshot

Ligand Pharmaceuticals Incorporated (LGND) has a DilutionScore of 15/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

LGND's DilutionScore is currently 15/100 (Low risk), with 5 score changes tracked over 89 days. The score deteriorated from 16/100 (Low risk).

Period Score Risk Level Duration
Oct 10 – Oct 13, 202615/100LOW4 days
Sep 29 – Oct 09, 202616/100LOW11 days
Aug 22 – Sep 28, 202622/100LOW38 days
Aug 14 – Aug 21, 202611/100LOW7 days
Jul 17 – Aug 13, 202622/100LOW28 days
Jul 16, 202621/100LOW1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

LGND shares outstanding have increased 1.3% from 19.68M (Mar 2026) to 19.94M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 07, 202619.94M19.47M▼ 0.02%
Mar 10, 202619.94M19.47M▲ 0.06%
Mar 05, 202619.68M19.46M▲ 0.03%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track LGND Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment LGND files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking LGND — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LGND
LGND FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.